Health Care: Health Services

WuXi PharmaTech (Cayman) Inc (WX: NYSE)

$43.5 -0.13 | -0.3%
05/22/15 - 04:02 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 674.28M 578.08M 499.91M 407.18M
Cost of Sales 376.18M 321.78M 275.00M 216.74M
Gross Operating Profit 298.10M 256.30M 224.91M 190.44M
Selling, General, and Administrative Expenses 126.80M 95.37M 85.66M 72.63M
Research & Development 21.22M 10.95M 8.14M 0.00
Operating Income before D & A (EBITDA) 150.09M 149.98M 131.12M 117.81M
Depreciation & Amortization 46.36M 44.74M 41.67M 34.00M
Interest Income 19.30M 11.49M 7.73M 6.06M
Other Income - Net 16.16M 23.25M 11.94M 8.51M
Special Income / Charges 0.00 0.00 -3.42M 0.00
Total Income Before Interest Expenses (EBIT) 139.19M 139.98M 105.70M 98.38M
Interest Expense 2.58M 1.95M 1.72M 790.00K
Pre-Tax Income 136.61M 138.03M 103.98M 97.58M
Income Taxes 24.45M 23.46M 17.39M 16.61M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 112.16M 114.57M 86.58M 80.98M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 112.16M 114.57M 86.58M 80.98M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 112.16M 114.57M 86.58M 80.98M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
112.16M 114.57M 90.00M 80.98M
Preferred Dividends
Net Income Available To Common 112.16M 114.57M 86.58M 80.98M
Basic EPS from Continuing Ops. 1.59 1.62 1.22 1.12
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.59 1.62 1.22 1.12
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.01 -0.02 -0.02 0.00
Basic EPS, Total 1.60 1.60 1.20 1.12
Basic Normalized Net Income/Share 1.59 1.62 1.27 1.12
EPS fr Continuing Ops. 1.56 1.57 1.19 1.04
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.56 1.57 1.19 1.04
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.04 0.03 0.01 0.00
EPS, Total 1.52 1.60 1.20 1.04
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.56 1.57 1.24 1.04
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with WX

Latest WX Headlines from TheStreet

More Financial News for WX

Press Releases for WX

See All Press Releases

Partner Headlines for WX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter